Cbl-b基因沉默增强T细胞对人喉鳞癌细胞Hep-2的免疫杀伤效果 |
| |
引用本文: | 陈赛明,李智群,周利民,张云霞.Cbl-b基因沉默增强T细胞对人喉鳞癌细胞Hep-2的免疫杀伤效果[J].南方医科大学学报,2019,39(5):554. |
| |
作者姓名: | 陈赛明 李智群 周利民 张云霞 |
| |
作者单位: | 海南医学院第一附属医院耳鼻咽喉头颈外科,海南 海口,570102;海南医学院科学实验中心,海南 海口,570102 |
| |
摘 要: | 目的研究泛素连接酶(Cbl-b)基因沉默对H9 人T淋巴细胞免疫杀伤人喉鳞癌细胞Hep-2 作用的影响和相关机制。方
法选择12例喉鳞癌患和12例健康对照者,用磁性细胞分离技术分离外周血CD4+T细胞应用RT-PCR法检测Cbl-b的表达水
平。同时,将人T淋巴细胞H9 接种培养于96 孔板,分为4 组:以脂质体转染法将Cbl-b-siRNA 重组序列转染人T淋巴细胞
H9,作为Cbl-b-siRNA组;Cbl-b-siRNA重组序列转染T细胞成功后,在其培养液中加入IL-2 中和抗体,作为anti-IL-2+Cbl-bsiRNA
组;以脂质体转染法将随机阴性对照序列转染的人T淋巴细胞H9 作为阴性组(NC组);以不做任何处理人T淋巴细
胞H9 为空白组(BC组)。采用倒置荧光显微镜观察人T淋巴细胞H9 的转染效率、以实时荧光定量PCR法和蛋白免疫印迹
法检测各组人T 淋巴细胞H9 中Cbl-b mRNA和蛋白表达情况。以细胞计数试剂盒(CCK-8)检测各组人T 淋巴细胞H9 对
Hep-2细胞的杀伤作用;流式细胞仪检测各组人T淋巴细胞H9表面活化分子CD69、CD25阳性表达率;采用ELISA法检测T细
胞上清液中白介素-2(IL-2)、γ干扰素(INF-γ)水平。结果Cbl-b mRNA在喉鳞癌患者CD4+T细胞中表达升高,与健康对照差异
有显著性(P<0.05)。Cbl-b-siRNA组和阴性组的转染效率分别为(78.30±6.06)%、(77.25±6.38)%,转染效果良好;Cbl-b-siRNA
组人T淋巴细胞H9 的Cbl-b mRNA和蛋白相对表达量与anti-IL-2+Cbl-b-siRNA组无显著差异(P>0.05),但显著低于空白组
和阴性组(P<0.05);不同效靶比时,Cbl-b-siRNA组Hep-2 肿瘤细胞杀伤率均显著高于anti-IL-2+Cbl-b-siRNA组、阴性组和空
白组(P<0.05)。Cbl-b-siRNA 组人T淋巴细胞H9 表面活化分子CD69、CD25 阳性表达率均显著高于anti-IL-2+Cbl-b-siRNA
组、空白组和阴性组(P<0.05);Cbl-b-siRNA 组人T 淋巴细胞H9 上清液中INF-γ、IL-2 水平均显著高于空白组和阴性组(P<
0.05);空白组与阴性组人T淋巴细胞H9 的Cbl-b mRNA和蛋白相对表达量、肿瘤细胞杀伤率、表面活化分子CD69、CD25 阳
性表达率、上清液中IL-2、INF-γ水平比较差异均不显著(P>0.05)。结论应用siRNA技术沉默T细胞Cbl-b 基因可有效增强
人T淋巴细胞H9 对人喉鳞癌细胞株Hep-2 体外免疫杀伤作用,其机制可能与T细胞Cbl-b 基因沉默促进人T淋巴细胞H9 分
泌IL-2、加强T淋巴细胞激活有关。
|
关 键 词: | 基因沉默 泛素连接酶 人喉鳞癌 免疫杀伤 |
Cbl-b gene silencing enhances H9 T lymphocyte-mediated killing of human laryngeal
squamous cancer Hep-2 cells |
| |
Abstract: | Objective To investigate the effect of sputum ubiquitin ligase (Cbl-b) gene known-down on the cytotoxicity of H9 T
lymphocytes against human laryngeal squamous cancer Hep-2 cells and explore the underlying mechanism. Methods CD4+ T
lymphocytes isolated from 12 patients with laryngeal squamous carcinoma and 12 healthy individuals were examined for
Cbl-b mRNA expressions using RT-PCR. H9 T lymphocytes cultured in 96-well plates were transfected with Cbl-b siRNA via
liposomes followed by treatment with an anti-IL-2 monoclonal antibody, with H9 T lymphocytes transfected with a scrambled
sequence as the negative control. The expressions of Cbl-b mRNA and protein in the cells were detected using real-time
fluorescent quantitative PCR and Western blotting, respectively. The killing effect of the treated T lymphocytes against Hep-2
cells was assessed using the cell counting kit (CCK-8). The positive expression rates of CD69 and CD25 on the surface of H9 T
lymphocytes were determined using flow cytometry, and the levels of interleukin-2 (IL-2) and interferon-gamma (INF-γ) in the
culture supernatants of H9 T lymphocytes were detected with ELISA. Results The CD4 + T lymphocytes from patients with
laryngeal squamous carcinoma showed significantly increased Cbl-b mRNA level compared with those from healthy
individuals (P<0.05). Transfection of H9 T lymphocytes with Cbl-b siRNA significantly reduced the expression levels of Cbl-b
mRNA and protein (P<0.05), which were not significantly affected by subsequent treatment of the cells with the anti-IL-2
antibody (P>0.05). At different target-effector ratios, the Cbl-b siRNA-transfected cells showed significantly higher Hep-2 cell
killing rates and higher positivity rates of CD69 and CD25 expressions than the blank and negative control cells and the cells
with both Cbl-b siRNA transfection and anti-IL-2 treatment (P<0.05). Cbl-b silencing in H9 T lymphocytes resulted in
significantly increased levels of IL-2 and INF-γ in the supernatant as compared with those in the blank and negative control
groups (P<0.05). Conclusion Cbl-b gene silencing
effectively enhances the killing effect of H9 T
lymphocytes against Hep-2 cells in vitro probably as
the result of enhanced IL-2 secretion and T
lymphocyte activation. |
| |
Keywords: | |
本文献已被 万方数据 等数据库收录! |
| 点击此处可从《南方医科大学学报》浏览原始摘要信息 |
| 点击此处可从《南方医科大学学报》下载免费的PDF全文 |
|